247 related articles for article (PubMed ID: 28615111)
1. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111
[TBL] [Abstract][Full Text] [Related]
2. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
[TBL] [Abstract][Full Text] [Related]
3. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
[TBL] [Abstract][Full Text] [Related]
4. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
[TBL] [Abstract][Full Text] [Related]
7. A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities.
Kanti Das S; Mishra S; Manna K; Kayal U; Mahapatra S; Das Saha K; Dalapati S; Das GP; Mostafa AA; Bhaumik A
Chem Commun (Camb); 2018 Oct; 54(81):11475-11478. PubMed ID: 30256355
[TBL] [Abstract][Full Text] [Related]
8. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
Kushwaha N; Sharma CS
Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
10. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review.
Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A
Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709
[TBL] [Abstract][Full Text] [Related]
11. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities.
Dinh Ngoc T; Moons N; Kim Y; De Borggraeve W; Mashentseva A; Andrei G; Snoeck R; Balzarini J; Dehaen W
Bioorg Med Chem; 2014 Jul; 22(13):3292-300. PubMed ID: 24844757
[TBL] [Abstract][Full Text] [Related]
13. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
Verma T; Sinha M; Bansal N
Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F; Gdaniec M
Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
Zhou X; Lin K; Ma X; Chui WK; Zhou W
Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of uncondensed 1,2,4-triazines, Part IV. Synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds--an overview.
Abdel-Rahman RM
Pharmazie; 2001 Apr; 56(4):275-86. PubMed ID: 11338663
[TBL] [Abstract][Full Text] [Related]
19. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
Jin GF; Ban HS; Nakamura H; Lee JD
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]